4D MOLECULAR THERAPEUTICS IN (FDMT) Stock Cash Flow
NASDAQ:FDMT - Nasdaq - US35104E1001 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -176.44M | -160.87M | -100.84M | -107.49M | -71.32M | |||
| Depreciation Amortization | 7.29M | 6.71M | 5.75M | 2.40M | 1.52M | |||
| Change In Working Capital | -3.11M | 537.00K | 630.00K | -1.34M | -15.53M | |||
| Other non cash items | 19.01M | 19.04M | 18.67M | 19.74M | 16.19M | |||
| OPERATING CASH FLOW | -153.25M | -134.59M | -75.79M | -86.69M | -69.13M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.71M | -3.79M | -2.77M | -11.54M | -9.11M | |||
| Other Investing Activity | -3.52M | -298.65M | 118.49M | -5.51M | -163.57M | |||
| INVESTING CASH FLOW | -7.23M | -302.44M | 115.72M | -17.05M | -172.68M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | N/A | 337.25M | 156.83M | 3.55M | 118.09M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -470.00K | N/A | |||
| FINANCING CASH FLOW | N/A | 337.25M | 156.83M | 3.09M | 118.09M | |||
| CHANGE IN CASH | -142.07M | -99.77M | 196.76M | -100.65M | -123.72M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -153.25M | -134.59M | -75.79M | -86.69M | -69.13M | |||
| Capital Expenditure | -3.71M | -3.79M | -2.77M | -11.54M | -9.11M | |||
| FREE CASH FLOW | -156.96M | -138.37M | -78.56M | -98.23M | -78.24M | |||
All data in USD